0001438133-21-000199.txt : 20211103 0001438133-21-000199.hdr.sgml : 20211103 20211103165347 ACCESSION NUMBER: 0001438133-21-000199 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211101 FILED AS OF DATE: 20211103 DATE AS OF CHANGE: 20211103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBERTSON REBECCA B CENTRAL INDEX KEY: 0001201585 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 211376265 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 4 1 wf-form4_163597280304758.xml FORM 4 X0306 4 2021-11-01 0 0001438133 TANDEM DIABETES CARE INC TNDM 0001201585 ROBERTSON REBECCA B C/O TANDEM DIABETES CARE, INC. 11075 ROSELLE STREET SAN DIEGO CA 92121 1 0 0 0 Common Stock 2021-11-01 4 M 0 1108 34 A 1500 D Common Stock 2021-11-01 4 S 0 1222 135.64 D 278 D Common Stock 2021-11-01 4 S 0 278 136.35 D 0 D Stock Option 34.0 2021-11-01 4 M 0 1108 34 A Common Stock 1108.0 34892 D Represents shares of common stock received upon exercise of a stock option award. The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $135.05 to $136.04. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $136.19 to $136.53. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. The option shall vest in 36 equal monthly installments from January 2, 2019, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). The expiration date for these options is 10 years from the date of grant. s/ David B. Berger, Attorney-in-Fact for Rebecca B. Robertson 2021-11-03